Defeating this scourge will be the President-elect's greatest challenge
By Kenneth E. Thorpe - - Wednesday, December 16, 2020
ANALYSIS/OPINION:
COVID-19 has killed more than 300,000 Americans. And with case counts and hospitalizations soaring, many
Sacrificing regular doctor visits in order to socially distance is not a good idea. Here’s why
By KENNETH E. THORPE
DECEMBER 6, 2020 7:00PM (UTC)
Millions of Americans have postponed lifesaving screenings and other preventative care due to COVID-19, according to an
WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump Administration’s Final Rule to extend benefits of drug rebates to Medicare beneficiaries:
“Rebates lower drug costs for insurers, but
Proposed "Most Favored Nation" Medicare model will hinder biomedical research and harm Medicare beneficiaries living with chronic diseases
WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump
By Kenneth E. Thorpe
President Trump has long promised to lower prescription drug prices. Unfortunately, two of his administration’s newest proposals would actually raise out-of-pocket costs and reduce access to medicines.
They must be scrapped before they do real
WASHINGTON, D.C. (September 28, 2020) -- Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement in response to President Donald Trump's America-First Healthcare Plan executive order:
"President Trump's latest executive order claims
The "Most Favored Nations" Executive Order will harm patients by hindering biomedical research
WASHINGTON, D.C. (September 14, 2020) -- Kenneth Thorpe, chairman of the Partnership to Fight Chronic Disease, issued the following statement in response to
"Favored Nations Rule" will reduce access to medicines and stifle biomedical research
WASHINGTON, D.C. (July 24, 2020) – Kenneth Thorpe, Chairman of the Partnership to Fight Chronic Disease, has issued the following statement in response to President Donald Trump's
Collaboration, investment and action essential to advancing greater overall health
July 9, 2020 (Washington, D.C.) The Partnership to Fight Infectious Disease (PFID) today released the following statement in response to the International Federation of Pharmaceutical Manufacturers &